A GLOW Blend peptide calculator helps estimate syringe units, mL dosing, and peptide concentration after mixing peptides with diluent
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
, L-
Sublingual forms appear similarly effective to standard oral tablets
The incidence rate of POTS has increased substantially from COVID-19, so these numbers have been growing
Krull S, Rissmann A, Krause H, Mohnike K, Roehl F, Koehn A, Hass H (2018) Outcome after Hypospadias Repair: Evaluation Using the Hypospadias Objective Penile Evaluation Score